SpectronRx
Holly Ward is a qualified professional with extensive experience in quality control and research and development within the chemical and adhesive industries. Currently serving as QC Manager at SpectronRx since June 2021, Holly specializes in various assays and testing methodologies, including immunoreactivity and protein analysis, while also contributing to the creation of standard operating procedures. Previous roles include Engineering Adhesives Lab Technician II at H.B. Fuller, focusing on R&D for water and solvent-based adhesives, and Associate Research Scientist at Serim Research Corporation, where responsibilities included product formulation and quality assurance. Holly holds a Bachelor of Science in Chemistry from Indiana University South Bend, earned in 2016.
This person is not in any offices
SpectronRx
1 followers
SpectronRx is a CDMO that is FDA and EMA inspected. We are licensed to handle multiple Therapeutic and Diagnostic isotopes pharmaceutical grade including Pb-212, Lu-177, Ac-225 and I-131 for various clinical applications. Spectron operates under a quality program that has been inspected by the FDA with approved drugs FDG, NaF and Ammonia. Spectron provides labeling and contract manufacturing services as it relates to Lu-177, Ac-225, I-131, I-124, I-111, Zr-89, Copper-64 and Fluorine-18.